Glen Harbor Capital Management LLC - SIENNA BIOPHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 58 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Glen Harbor Capital Management LLC ownership history of SIENNA BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q4 2018$11,000
-96.0%
4,752
-74.5%
0.00%
-100.0%
Q3 2018$276,000
+2.6%
18,634
+5.1%
0.01%0.0%
Q2 2018$269,000
+41.6%
17,732
+75.6%
0.01%
+50.0%
Q1 2018$190,000–10,098–0.00%–
 Download
Other shareholders
SIENNA BIOPHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Golden State Wealth Management, LLC 180,552$36,0000.01%
MILLENNIUM MANAGEMENT LLC 122,942$24,0000.00%
CITIGROUP INC 1,739$00.00%
GOLDMAN SACHS GROUP INC 52,553$11,0000.00%
MORGAN STANLEY 101$00.00%
ACADIAN ASSET MANAGEMENT LLC 15,936$3,0000.00%
BANK OF MONTREAL /CAN/ 20$00.00%
BlackRock Inc. 90,036$18,0000.00%
Ballentine Partners, LLC 16,700$3,0000.00%
Citadel Advisors 83,839$17,0000.00%
View complete list of SIENNA BIOPHARMACEUTICALS IN shareholders